Prof. Dr. Ernst Wolvetang, The University of Queensland, AUS “Using CRISPR/Cas9 technologies to reveal the contribution of APP to Alzheimer’s disease in iPSC”
Date: Thursday, 30 March 2017 at 16:00
Venue: CECAD Research Center, Joseph-Stelzmann-Straße 26, lecture hall, ground floor
Host: Sara Wickström (MPI Age)